More News

Alphabet Crushes Q3 Earnings, Reports First $100 Billion Quarter

Today 12:20 EDT

Via MarketBeat

Rocket Lab Stock Dips 14%—Buying Opportunity Ahead?

Today 11:09 EDT

Via MarketBeat

CrowdStrike at All-Time High: Still a Buy, or Time to Trim?

Today 10:12 EDT

Via MarketBeat

NVIDIA: The FOMO Melt-Up Could Reach a $7 Trillion Market Cap

Today 9:58 EDT

Via MarketBeat

Broadcom: The Hidden Winner in Google's Anthropic Chip Deal?

Today 9:21 EDT

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	225.71	-4.59 (-2.00%)
AAPL	271.66	+1.96 (0.73%)
AMD	261.06	-3.27 (-1.24%)
BAC	53.16	+0.58 (1.10%)
GOOG	285.36	+10.19 (3.70%)
META	680.18	-71.49 (-9.51%)
MSFT	525.49	-16.06 (-2.97%)
NVDA	203.16	-3.88 (-1.87%)
ORCL	259.50	-15.80 (-5.74%)
TSLA	444.74	-16.77 (-3.63%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Company Website

More News

Recent Quotes